Literature DB >> 7751873

Who benefits from high-dose therapy for multiple myeloma?

K C Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7751873     DOI： 10.1200/JCO.1995.13.6.1291

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center.

Authors:  W Bensinger; M Rotta; B Storer; T Chauncey; L Holmberg; P Becker; B M Sandmaier; R Storb; D Maloney
Journal:  Bone Marrow Transplant       Date:  2012-02-13       Impact factor: 5.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.